Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
19.9K
-
Shares change
-
-33.7K
-
Total reported value, excl. options
-
$281K
-
Value change
-
-$475K
-
Number of sells
-
-1
-
Price
-
$14.12
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q4 2023
1 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q4 2023.
AVADEL PHARMACEUTICALS - COM (AVDL) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9K shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (11.1M shares), RTW INVESTMENTS, LP (6.95M shares), Polar Capital Holdings Plc (6.75M shares), GENDELL JEFFREY L (5.62M shares), Vivo Capital, LLC (4.1M shares), WEALTH EFFECTS LLC (2.42M shares), Woodline Partners LP (1.85M shares), COWEN AND COMPANY, LLC (1.64M shares), BRANDES INVESTMENT PARTNERS, LP (1.53M shares), and TANG CAPITAL MANAGEMENT LLC (1.08M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.